FundingHealthcare & Life Sciences
Lissun raises Rs 2.77 crore from existing investors
By Abha Lohia · Editor ·
Lissun valuation
Lissun was valued at Rs 101 crore (2026). Lissun reported revenue of Rs 5.13 crore in FY25, as reported by Entrackr on 17 June 2026.
| Valuation (2026) | Rs 101 crore |
|---|---|
| Revenue (FY25) | Rs 5.13 crore |
Lissun: revenue, valuation and funding and every story →
Series AFounded 2021
- The company raised Rs 2.77 crore via convertible notes and equity shares from Rainmatter, India Foundation Fund, and individual investors
- Proceeds will be used for general business purposes and working capital requirements
- This is Lissun's first capital infusion in almost two years following its pre-Series A round in September 2024
What happened
- Lissun raised Rs 2.77 crore in fresh funding from existing investors.
- The investment came from Rainmatter, India Foundation Fund, and individual investors.
- Funds were raised via convertible notes and equity shares issued at specific prices.
- The post-money valuation stands at approximately Rs 101 crore.
- Proceeds will be used for general business purposes and working capital requirements.
- This marks the first capital infusion since September 2024.
- The board also approved stock options worth Rs 5.06 crore for senior management.
- The company has not yet filed its FY26 financial statements.
Why it matters
- This is Lissun's first funding round in almost two years.
- The previous round was a $2.5M pre-Series A led by RPSG Ventures.
- The new valuation represents a 40% increase from the previous Series A stage.
- Existing investors are continuing their support for the company's growth.
The business
- Lissun offers therapy, counseling, and wellness solutions for individuals and enterprises.
- Services include 1-on-1 video/chat sessions with counselors and psychologists.
- The platform provides group support communities and self-help tools like mood trackers.
- It serves over 75,000 clients across more than 40 cities.
- The company has onboarded 350+ B2B partners for enterprise solutions.
- FY25 operating revenue doubled to Rs 5.13 crore from the previous year.
- Lissun conducted over 1,05,000 sessions during its operational history.
- Operating losses increased to Rs 9.85 crore in FY25.
- The company acquired US-based Being Cares Inc last July.
The founders
- Co-founded Lissun in 2021.
- Holds the title of Doctor indicating medical or academic qualifications.
- Serves as a director eligible for stock option grants.
- Co-founded Lissun in 2021.
- Active director involved in recent board approvals.
- Eligible for stock options under the MSOP scheme.
Who put in money
- Rainmatter lead — Investment arm of ICICI Bank focusing on fintech startups.
- India Foundation Fund co-lead — Fund focused on supporting Indian social impact and health initiatives.
In numbers
Rs 101 croreValuation · 2026
Rs 5.13 croreOperating Revenue · FY25
Rs 9.85 croreOperating Losses · FY25
75,000+Clients Served · 2026
1,05,000+Sessions Conducted · 2026
What happens next
- Use funds for general business purposes and working capital.
- Continue expanding therapy and wellness services to more cities.
- Grow B2B partnerships with enterprises.
Earlier rounds
- Sep 2024 · Pre-Series A · $2.5M · led by RPSG Ventures
Words to know
- Convertible Notes
- Debt that converts into equity later, usually at a discount.
- MSOP
- Management Stock Option Plan granting shares to employees.
The numbers around it
Lissun has 2 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 18 August 2026 | Series A | ₹48 crore ($5.7M est) | Colossa Ventures |
Healthcare & Life Sciences in June 2026: 11 rounds with a disclosed amount, $118 million in all; the biggest was Vetic ($40 Mn). Every sector this year →
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Pre-Series A: A pre-Series A round is money raised after a seed round and before a full Series A, so that a startup can reach the revenue, growth and retention Series A investors expect. In India such rounds commonly run from about ₹5 crore to ₹40 crore, and the label itself is informal.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
- Convertible note: A convertible note is a short-term loan that a startup repays in shares instead of cash when it raises its next priced round, usually at a discount or under a valuation cap. In India a DPIIT-recognised startup can issue one without it counting as a deposit, subject to conditions such as a commonly cited ₹25 lakh minimum.
Read next
FundingLissun raises ₹48 crore in Series A funding roundLissun operates physical centres for child therapy and digital mental health toolsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Lissun → · All startup news on 17 June 2026 →
Is this Lissun? Get your “Featured on StopDown” badge →